Obesity Increases Prevalence of Colonic Adenomas at Screening Colonoscopy: A Canadian Community-Based Study.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28781966)

Published in Can J Gastroenterol Hepatol on July 11, 2017

Authors

Theodore F Shapero1, Grant I Chen1, Tim Devlin1, Alison Gibbs2, Iain C Murray3, Stanley Tran4, Corey Weigensberg5

Author Affiliations

1: Department of Medicine, The Scarborough Hospital, Scarborough, ON, Canada.
2: Department of Statistical Sciences, University of Toronto, Toronto, ON, Canada.
3: Intestinal Health Institute, Markham, ON, Canada.
4: Department of Medicine, The Scarborough Hospital and North Toronto Endoscopy Clinic, Scarborough, ON, Canada.
5: Department of Pathology, The Scarborough Hospital, Scarborough, ON, Canada.

Articles cited by this

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (2008) 20.62

Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study. Ann Intern Med (2015) 3.45

Obesity and colorectal cancer. Gut (2013) 3.29

Race, ethnicity, and sex affect risk for polyps >9 mm in average-risk individuals. Gastroenterology (2014) 3.03

A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut (2014) 1.83

Obesity and colorectal cancer risk in women. Gut (2002) 1.79

Recommendations on screening for colorectal cancer in primary care. CMAJ (2016) 1.52

Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obes (Lond) (2007) 1.32

Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology (2012) 1.30

Lifestyle as a predictor for colonic neoplasia in asymptomatic individuals. BMC Gastroenterol (2006) 1.28

Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study. Am J Epidemiol (2009) 1.21

Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology (2013) 1.18

Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site. Am J Epidemiol (2013) 1.14

Metabolic syndrome components and colorectal adenoma in the CLUE II cohort. Cancer Causes Control (2009) 1.13

Visceral fat area and markers of insulin resistance in relation to colorectal neoplasia. Diabetes Care (2009) 1.12

Stepwise relationship between components of metabolic syndrome and risk of colorectal adenoma in a Taiwanese population receiving screening colonoscopy. J Formos Med Assoc (2011) 1.03

Personalizing colorectal cancer screening: a systematic review of models to predict risk of colorectal neoplasia. Clin Gastroenterol Hepatol (2014) 1.01

Abdominal visceral adipose tissue predicts risk of colorectal adenoma in both sexes. Clin Gastroenterol Hepatol (2010) 1.00

Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can). Cancer (2010) 0.99

Association between visceral adiposity and colorectal polyps on CT colonography. AJR Am J Roentgenol (2012) 0.97

A Risk Prediction Index for Advanced Colorectal Neoplasia at Screening Colonoscopy. Am J Gastroenterol (2015) 0.87

The comparison of the clinical manifestations and risk factors of colorectal cancer and adenomas: results from a colonoscopy-based study in southern Chinese. Int J Colorectal Dis (2010) 0.79

Is obesity a risk factor for advanced colon polyps in males? Hepatogastroenterology (2011) 0.77

Tailoring colonoscopic screening to individual risk. Gastroenterology (2014) 0.77